QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

 

 

 

Delaware (State or Other Jurisdiction of Incorporation or Organization)

11-2936371 (I.R.S. Employer Identification No.)

 

600 California Street, 9th Floor San Francisco, CA (Address of Principal Executive Offices)

94108 (Zip Code)

 

 

 

Large accelerated filer  ¨

Accelerated filer  x

Non-accelerated filer  ¨

 

 

	Page No.
PART I FINANCIAL INFORMATION
ITEM 1. Financial Statements (unaudited)
Condensed Consolidated Statements of Operations For the Three Months and Six Months Ended June 30, 2007 and 2006	2
Condensed Consolidated Statements of Financial Condition as of June 30, 2007 and December 31, 2006	3
Condensed Consolidated Statements of Cash Flows For the Six Months Ended June 30, 2007 and 2006	4
Notes to Condensed Consolidated Financial Statements	5
ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations	15
ITEM 3. Quantitative and Qualitative Disclosures About Market Risk	24
ITEM 4. Controls and Procedures	24
PART II OTHER INFORMATION
ITEM 1. Legal Proceedings	25
ITEM 1A. Risk Factors	25
ITEM 4. Submission of Matters to a Vote of Security Holders	31
ITEM 6. Exhibits	32
Signatures	33
Certifications

 

MCF CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION

(unaudited)

 

	June 30, 2007			December 31, 2006
ASSETS
Cash and cash equivalents	$	16,130,529		$	13,746,590
Securities owned:
Marketable, at fair value		13,690,559			7,492,914
Not readily marketable, at estimated fair value		1,717,282			1,489,142
Restricted cash		631,968			629,427
Due from clearing broker		1,126,441			551,831
Accounts receivable, net		2,870,376			2,715,271
Equipment and fixtures, net		1,387,904			1,586,630
Intangible assets		2,479,357			314,963
Goodwill		3,171,969			─
Prepaid expenses and other assets		1,453,589			1,971,445
Total assets	$	44,659,974		$	30,498,213
LIABILITIES AND STOCKHOLDERS' EQUITY
Accounts payable	$	2,269,120		$	1,121,623
Commissions and bonus payable		6,531,294			7,711,805
Accrued expenses		4,137,359			2,285,670
Due to clearing and other brokers		21,858			11,114
Securities sold, not yet purchased		4,177,032			1,534,953
Capital lease obligation		987,880			1,292,378
Convertible notes payable, net		192,247			187,079
Notes payable		90,556			138,571
Total liabilities		18,407,346			14,283,193
Commitments and contingencies
Stockholders' equity:
Preferred stock, Series A--$0.0001 par value; 2,000,000 shares authorized; 0 shares issued and outstanding as of June 30, 2007 and December 31, 2006, respectively; aggregate liquidation preference of $0		─			─
Preferred stock, Series B--$0.0001 par value; 12,500,000 shares authorized; 1,250,000 shares issued and 0 shares outstanding as of June 30, 2007 and December 31, 2006; aggregate liquidation preference of $0		─			─
Preferred stock, Series C--$0.0001 par value; 14,200,000 shares authorized; 1,685,714 shares issued and 0 shares outstanding as of June 30, 2007 and December 31, 2006; aggregate liquidation preference of $0		─			─
Common stock, $0.0001 par value; 300,000,000 shares authorized; 12,160,458 and 10,602,720 shares issued and 12,134,020 and 10,602,720 shares outstanding as of June 30, 2007 and December 31, 2006, respectively		1,217			1,061
Additional paid-in capital		122,390,284			114,616,848
Treasury stock		(125,613	)		--
Accumulated deficit		(96,013,260	)		(98,402,889	)
Total stockholders' equity		26,252,628			16,215,020
Total liabilities and stockholders' equity	$	44,659,974		$	30,498,213

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

---

 

MCF CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

 

	Six Months Ended June 30,
	2007			2006
Cash flows from operating activities:
Net income (loss)	$	2,389,629		$	(2,409,543	)
Adjustments to reconcile net income (loss) to cash provided by (used in) operating activities:
Depreciation and amortization		363,048			336,935
Amortization of intangible assets		220,643			─
Stock-based compensation		1,451,862			1,982,049
Amortization of discounts on convertible notes payable		5,166			150,840
Amortization of debt issuance costs		─			15,305
Unrealized (gain) loss on securities owned		(5,680,368	)		1,255,288
Bad debt write-off		228,167			─
Other		31,304			13,055
Changes in operating assets and liabilities:
Securities owned		1,896,662			(3,178,269	)
Restricted cash		(2,541	)		(256,408	)
Due from clearing broker		(574,610	)		(514,899	)
Accounts receivable		628,898			(478,082	)
Prepaid expenses and other assets		667,994			(773,889	)
Accounts payable		570,326			231,173
Commissions and bonus payable		(1,368,234	)		(631,920	)
Accrued expenses		1,671,655			(185,204	)
Due to clearing and other brokers		10,744			(4,108	)
Net cash provided by (used in) operating activities		2,510,345			(4,447,677	)
Cash flows from investing activities:
Cash restricted for fund investment		─			(6,639,366	)
Purchase of equipment and fixtures		(118,021	)		(268,786	)
Investment in MedPanel		(24,585	)		─
Investment in Catalyst		163,219			(58,558	)
Net cash provided by (used in) investing activities		20,613			(6,966,710	)
Cash flows from financing activities:
Proceeds from the exercise of stock options and warrants		102,937			289,089
Proceeds from the issuance of common stock		102,555			339,430
Proceeds from the issuance of note payable ($6,112,171) and stock warrant ($1,387,829)		─			7,500,000
Minority interest in fund		─			2,192,943
Debt service principal payments		(352,511	)		(228,047	)
Net cash provided by (used in) financing activities		(147,019	)		10,093,415
Increase (decrease) in cash and cash equivalents		2,383,939			(1,320,972	)
Cash and cash equivalents at beginning of period		13,746,590			11,138,923
Cash and cash equivalents at end of period	$	16,130,529		$	9,817,951
Supplementary disclosure of cash flow information:
Cash paid during the period:
Interest	$	51,039		$	39,265
Income taxes	$	─		$	10,300
Reclassification of deferred compensation	$	─		$	3,146,839

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

---

MCF CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

 

1. Significant Accounting Policies

 

Basis of Presentation

 

The interim financial statements included herein for MCF Corporation, or the Company, have been prepared, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of management, the financial statements included in this report reflect all normal recurring adjustments that the Company considers necessary for the fair presentation of the results of operations for the interim periods covered and the financial position of the Company at the date of the interim statement of financial condition. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to such rules and regulations. However, the Company believes that the disclosures are adequate to understand the information presented. The operating results for interim periods are not necessarily indicative of the operating results for the entire year. These financial statements should be read in conjunction with the Company's 2006 audited consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2006.

Reverse Stock Split

 

On August 4, 2006, the Company's Board of Directors approved a one-for-seven reverse stock split of the Company's common stock. The reverse stock split became effective at 11:59 pm, Eastern Time, on November 15, 2006. Pursuant to the reverse stock split, each seven shares of authorized and outstanding common stock was reclassified and combined into one share of new common stock. The reverse stock split did not change the number of authorized shares or the par value per share of common stock or preferred stock designated by the Company's Certificate of Incorporation. Currently, the Company has authorized 300,000,000 shares of common stock and 27,450,000 shares of preferred stock. All references to share and per share data for all periods presented have been retroactively adjusted to give effect to the one-for-seven reverse stock split.

Acquisition of MedPanel, Inc.

On April 17, 2007, MCF Corporation completed the acquisition of MedPanel, Inc., or MedPanel, a privately-held company based in Cambridge, Massachusetts, pursuant to the terms of the Agreement and Plan of Merger dated November 6, 2006, by and among MCF Corporation, MedPanel Acquisition I Corp., Panel Intelligence, LLC, MedPanel, Inc. and William J. Febbo. MedPanel is an online medical market intelligence firm that serves life sciences companies and health care investors through its proprietary methodologies and vast network of leading physicians, medical researchers, allied health professionals and other important healthcare constituencies.

Securities Owned

“Securities owned” and “Securities sold, but not yet purchased” in the consolidated statements of financial condition consist of financial instruments carried at fair value or amounts that approximate fair value, with related unrealized gains or losses recognized in the results of operations. The fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced or liquidation sale.

Fair values of the financial instruments are generally obtained from quoted market prices in active markets, broker or dealer price quotations, or alternative pricing sources with reasonable levels of price transparency. To the extent certain financial instruments trade infrequently or are non-marketable securities and, therefore, have little or no price transparency, the Company values these instruments based on management's estimates. The fair value of these securities is subject to a high degree of volatility and may be susceptible to significant fluctuation in the near term. Securities that contain resale restrictions are stated at a discount to the value of readily marketable securities. Stock warrants are carried at a discount to fair value as determined by using the Black-Scholes Option Pricing model due to illiquidity.

5

---

 

MCF CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS--CONTINUED

(unaudited)

 

1. Significant Accounting Policies - Continued

 

Investment Banking Revenue

 

Investment banking revenue includes underwriting and private placement agency fees earned through the Company's participation in public offerings and private placements of equity and convertible debt securities and fees earned as financial advisor in mergers and acquisitions and similar transactions. Underwriting revenue is earned in securities offerings in which the Company acts as an underwriter and includes management fees, selling concessions and underwriting fees. Fee revenue relating to underwriting commitments is recorded when all significant items relating to the underwriting cycle have been completed and the amount of the underwriting revenue has been determined. This generally is the point at which all of the following have occurred: (i) the issuer's registration statement has become effective with the SEC, or other offering documents are finalized, (ii) the Company has made a firm commitment for the purchase of the shares or debt from the issuer, and (iii) the Company has been informed of the exact number of shares or the principal amount of debt that it has been allotted. Syndicate expenses related to securities offerings in which the Company acts as underwriter or agent are deferred until the related revenue is recognized or we determine that it is more likely than not that the securities offerings will not ultimately be completed. Merger and acquisition fees and other advisory service revenue are generally earned and recognized only upon successful completion of the engagement. Underwriting revenue is presented net of related expenses. Unreimbursed expenses associated with private placement and advisory transactions are recorded as expenses as incurred. As co-manager for registered equity underwriting transactions, management must estimate the Company's share of transaction related expenses incurred by the lead manager in order to recognize revenue. Transaction related expenses are deducted from the underwriting fee and therefore reduces the revenue that is recognized as co-manager. Such amounts are adjusted to reflect actual expenses in the period in which the Company receives the final settlement, typically 90 days following the closing of the transaction.

Commissions and Principal Transactions Revenue

Commissions revenue includes revenue resulting from executing stock exchange-listed securities, over-the counter securities and other transactions as agent for the Company's clients. Principal transactions consist of a portion of dealer spreads attributed to the Company's securities trading activities as principal in NASDAQ-listed and other securities, and include transactions derived from activities as a market-maker. Additionally, principal transactions include gains and losses resulting from market price fluctuations that occur while holding positions in trading security inventory. Commissions revenue and related clearing expenses are recorded on a trade-date basis as security transactions occur. Principal transactions in regular-way trades are recorded on the trade date, as if they had settled. Profit and loss arising from all securities and commodities transactions entered into for the account and risk of the Company are recorded on a trade-date basis. 

Primary Research Revenue

Revenue from primary research services is recognized on a proportional performance basis as services are provided.

Cost of Primary Research Services

Direct costs associated with generating primary research revenue principally consist of panelist honorarium and recruitment costs. Medical experts receive cash honoraria for participating in qualitative panels and quantitative surveys. The Company pays the honoraria to the panelists when the panel or survey has been completed and records this expense as incurred.

Share-Based Compensation Expense

The Company measures and recognizes compensation expense based on estimated fair values for all share-based awards made to employees and directors, including stock options, non-vested stock, and participation in the Company's employee stock purchase plan. The Company estimates fair value of share-based awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense in the Company's consolidated statements of operations over the requisite service periods. Share-based compensation expense recognized in the Company's consolidated statement of operations includes compensation expense for share-based awards granted (i) prior to, but not yet vested as of December 31, 2005, based on the grant date fair value, and (ii) subsequent to December 31, 2005. Compensation expense for all share-based awards subsequent to December 31, 2005 is recognized using the straight-line single-option method. Because share-based compensation expense is based on awards that are ultimately expected to vest, share-based compensation expense has been reduced to account for estimated forfeitures. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.

6

---

 

MCF CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS--CONTINUED

(unaudited)

 

1. Significant Accounting Policies - Continued

 

To calculate option-based compensation, the Company uses the Black-Scholes option pricing model, which is affected by the Company's stock price as well as assumptions regarding a number of subjective variables. These variables include, but are not limited to the Company's expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors. No tax benefits were attributed to the share-based compensation expense because a valuation allowance was maintained for all net deferred tax assets.

Income Taxes

The Company uses the asset and liability method of accounting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. A valuation allowance is recorded to reduce deferred tax assets to an amount whose realization is more likely than not. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the consolidated statements of operations in the period that includes the enactment date.

Segment Reporting

The Company organizes its operations into three operating segments for the purpose of making operating decisions and assessing performance. These operating segments are organized along operating subsidiaries, Merriman Curhan Ford & Co, MCF Asset Management, LLC and Panel Intelligence, LLC. Accordingly, the Company operates in Investment Banking and Asset Management operating segments in the United States during 2007 and 2006, and added a Primary Research operating segment in April 2007 with the acquisition of MedPanel (see Note No. 3). However, only the Investment Banking segment produced operating results that were material to the Company during the three months and six months ended June 30, 2007. Total assets for Panel Intelligence were $7,806,000 as of June 30, 2007. The results of operations for the Company’s Wealth Management segment for the three months and six months ended June 30, 2006 have been treated as discontinued operations since this business was sold in January 2007 (see Note No. 4).

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses. Actual results could differ from those estimates. 

New Accounting Pronouncements

In September 2006, the Financial Accounting Standards Board (FASB) issued SFAS 157, “Fair Value Measurements.” SFAS 157 defines fair value, establishes a framework for measuring fair value under generally accepted accounting principles, and expands disclosures about fair value measurements. SFAS 157 is effective for financial statements issued for fiscal years beginning after November 15, 2007, and interim periods within those fiscal years. The Company is currently evaluating the impact the adoption of this statement could have on its financial condition, results of operations and cash flows.

In February 2007, the FASB issued SFAS No. 159, “Fair Value Option for Financial Assets and Financial Liabilities”, which permits entities to choose to measure many financial instruments and certain other items at fair value that are not currently required to be measured at fair value and establishes presentation and disclosure requirements designed to facilitate comparisons between entities that choose different measurement attributes for similar types of assets and liabilities. SFAS No. 159 is effective for fiscal years beginning after November 15, 2007. The Company is currently evaluating the impact, if any, that the adoption of SFAS No. 159 will have on its consolidated statements of financial condition, operations and cash flows.

7

---

 

MCF CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS--CONTINUED

(unaudited)

 

1. Significant Accounting Policies - Continued

 

In June 2007, the American Institute of Certified Public Accountants (AICPA) issued Statement of Position (SOP) No. 07-1, “Clarification of the Scope of the Audit and Accounting Guide ‘Audits of Investment Companies’ and Accounting by Parent Companies and Equity Method Investors for Investments in Investment Companies.” SOP No. 07-1 clarifies when an entity may apply the provisions of the Audit and Accounting Guide for Investment Companies (the Guide). Investment companies that are within the scope of the Guide report investments at fair value; consolidation or use of the equity method for investments is generally not appropriate. SOP No. 07-1 also addresses the retention of specialized investment company accounting by a parent company in consolidation or by an equity method investor. SOP No. 07-1 is effective for fiscal years beginning on or after December 15, 2007 with early adoption encouraged. In May 2007, the FASB issued FSP FIN No. 46-R-7, “Application of FIN 46-R to Investment Companies,” which amends FIN No. 46-R to make permanent the temporary deferral of the application of FIN No. 46-R to entities within the scope of the revised Guide under SOP No. 07-1. FSP FIN No. 46-R-7 is effective upon adoption of SOP No 07-1. The firm is evaluating the impact of adopting SOP No. 07-1 and FSP FIN No. 46-R-7 on its financial condition, results of operations and cash flows.

2. Share-Based Compensation Expense

Stock Options

As of June 30, 2007, there were 5,591,430 shares authorized for issuance under the Option Plans, and 612,858 shares authorized for issuance outside of the Option Plans. As of June 30, 2007, 579,974 shares were available for future option grants under the Option Plans. There were no shares available for future option grants outside of the Options Plans. Compensation expense for stock options during the three months and six months ended June 30, 2007 was $329,000 and $649,000, respectively. Compensation expense for stock options during the three months and six months ended June 30, 2006 was $319,000 and $641,000, respectively.

The following table is a summary of the Company's stock option activity for the six months ended June 30, 2007:

 

		Options Outstanding			Weighted  Average  Exercise Price
Balance as of December 31, 2006			3,570,370		$	6.19
Granted			408,132			4.72
Exercised			(39,583	)		(2.60	)
Canceled			(65,721	)		(7.33	)
Balance as of June 30, 2007			3,873,198		$	6.05
Exercisable as of June 30, 2007			3,000,711		$	6.06

 The following table summarizes information with respect to stock options outstanding at June 30, 2007:

 

		Options Outstanding												Vested Options
Range of Exercise Price		Number			Weighted Average Remaining Contractual Life (Years)			Weighted Average Exercise Price			Aggregate Intrinsic Value			Number			Weighted Average Exercise Price			Aggregate Intrinsic Value
$ 0.00 -- $ 3.50			2,038,205			5.54		$	2.95		$	4,209,505			2,036,864		$	2.95		$	4,207,346
$ 3.51 -- $ 7.00			893,048			8.19		$	4.60			377,938			313,010			4.09			291,569
$ 7.01 -- $14.00			646,277			7.68		$	8.86			─			355,169			9.29			─
$14.01 -- $28.00			256,381			3.36		$	22.04			─			256,381			22.04			─
$28.01 -- $49.00			39,287			2.66		$	49.00			─			39,287			49.00			─
			3,873,198			6.34		$	6.05		$	4,587,443			3,000,711		$	6.06		$	4,498,915

 

8

---

 

MCF CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS--CONTINUED

(unaudited)

 

2. Share-Based Compensation Expense - continued

As of June 30, 2007, total unrecognized compensation expense related to unvested stock options was $3,038,000. This amount is expected to be recognized as expense over a weighted-average period of 1.43 years.

Non-Vested Stock

 

At the date of grant, the recipients of non-vested stock have most of the rights of a stockholder other than voting rights, subject to certain restrictions on transferability and a risk of forfeiture. Non-vested shares typically vest over a two to four year period beginning on the date of grant. The fair value of non-vested stock is equal to the market value of the shares on the date of grant. The Company recognizes the compensation expense for non-vested stock on a straight-line basis over the requisite service period. Compensation expense for non-vested stock during the three months and six months ended June 30, 2007 was $327,000 and $688,000, respectively. Compensation expense for non-vested stock during the three months and six months ended June 30, 2006 was $564,000 and $1,018,000, respectively.

The following table is a summary of the Company's non-vested stock activity for the six months ended June 30, 2007: 

		Non-Vested Stock Outstanding			Weighted Average Grant Date Fair Value			Intrinsic Value at June 30, 2007
Balance as of December 31, 2006			306,009		$	10.04
Granted			65,308			4.80
Vested			(167,787	)		(9.42	)
Canceled			(17,689	)		(8.72	)
Balance as of June 30, 2007			185,841		$	8.87		$	932,922

 

As of June 30, 2007, total unrecognized compensation expense related to non-vested stock was $1,163,000. This expense is expected to be recognized over a weighted-average period of 0.97 year.

 

2002 Employee Stock Purchase Plan

The Company offers an Employee Stock Purchase Plan, or ESPP, to its employees. As of June 30, 2007, 21,565 shares were available for issuance under the ESPP. Compensation expense for ESPP during the three months and six months ended June 30, 2007 was $58,000 and $115,000, respectively. Compensation expense for ESPP during the three months and six months ended June 30, 2006 was $95,000 and $182,000, respectively.

As of June 30, 2007, unrecognized compensation expense related to the ESPP was $74,000. This amount is expected to be recognized as expense over a weighted-average period of 0.32 year.

Fair Value and Assumptions Used to Calculate Fair Value

 

The weighted average fair value of each stock option granted for the three months and six months ended June 30, 2007 was $2.53 and $2.56, respectively. The weighted average fair value of each stock option granted for the three months and six months ended June 30, 2006 was $3.02 and $4.11, respectively. The fair value of each option award is estimated on the date of grant using the Black-Scholes Option Pricing Model, with the following assumptions for the six months ended June 30, 2007 and 2006: 

 

		Six months Ended June 30,
		2007			2006
Expected volatility			65.83	%		84.76	%
Expected life (years)			4.17			4.69
Risk-free interest rate			4.75	%		4.70	%
Expected dividend yield			0	%		0	%

9

---

 

MCF CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS--CONTINUED

(unaudited)

 

2. Share-Based Compensation Expense - continued

The weighted average fair value of the non-vested stock granted under the Company's stock option plans for the three months and six months ended June 30, 2007 was $4.44 and 4.80 per share, respectively. The weighted average fair value of the non-vested stock granted under the Company's stock option plans for the three months and six months ended June 30, 2006 was $8.96 and 7.84 per share, respectively. The fair value of the non-vested stock award is estimated on the date of grant using the intrinsic value method.

3. Acquisition of MedPanel, Inc.

 

On April 17, 2007, MCF Corporation acquired 100 percent of the outstanding common shares of MedPanel, Inc. The results of MedPanel’s operations have been included in the consolidated financial statements since that date. MedPanel is an online medical market intelligence firm that serves life sciences companies and health care investors through its proprietary methodologies and vast network of leading physicians, medical researchers, allied health professionals and other important healthcare constituencies. As a result of the acquisition, the Company will provide independent market data and information to clients in the biotechnology, pharmaceutical, medical device, and financial industries by leveraging MedPanel’s proprietary methodology and vast network of medical experts.

The Company paid $6.5 million in common stock for MedPanel. The value of the 1,547,743 shares of common shares issued was determined based on the average market price of MCF Corporation’s common stock over the period including three days before and after the terms of the acquisition were agreed to and announced. The selling stockholders may also be entitled to additional consideration on the third anniversary from the closing which is based upon MedPanel achieving specific revenue and profitability milestones. The payment of the incentive consideration will be 50% in cash and 50% in the Company's common stock and may not exceed $11,455,000. The Company registered 1,548,119 shares of common stock with the Securities and Exchange Commission on Form S-4, file number 333-138870, originally filed November 21, 2006, as amended.

The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition. The Company is in the process of obtaining third-party valuations of certain intangible assets; thus, the allocation of the purchase price is subject to refinement.

 

		As of April 17, 2007
Cash and cash equivalents		$	670,028
Accounts receivable			1,023,325
Equipment and fixtures			86,088
Prepaid expenses and other assets			174,162
Intangible assets not subject to amortization:
Registered trademarks			710,000
Intangible assets subject to amortization:
Customer relationships (56 month weighted-average useful life)			990,000
Customer backlog (8 month weighted-average useful life)			420,000
Technology platform (30 month weighted-average useful life)			360,000
Database of registered panelists (24 weighted-average useful life)			220,000
Goodwill			3,171,969
Total assets acquired			7,825,572
Accounts payable			(577,171	)
Accrued expenses			(463,300	)
Total liabilities assumed			(1,040,471	)
Net assets acquired		$	6,785,101

The $3,172,000 of goodwill was assigned to our Primary Research segment.

10

---

 

MCF CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS--CONTINUED

(unaudited)

 

3. Acquisition of MedPanel, Inc. - continued

The following unaudited pro forma results of our operations for the three months and six months ended June 30, 2007 and 2006 assume the MedPanel acquisition occurred as of January 1, 2006. The pro forma results give effect to certain adjustments, including depreciation, amortization of intangible assets and related income tax effects. The pro forma results have been prepared for comparative purposes only and do not purport to indicate the results of operations which would actually have occurred had the combinations been in effect on the dates indicated or which may occur in the future.

 

		Three Months Ended						Six Months Ended
		June 30, 2007			June 30, 2006			June 30, 2007			June 30, 2006
Total revenue		$	20,767,434		$	16,258,906		$	36,823,895		$	29,193,187
Total operating expenses			18,609,716			17,046,534			34,936,942			31,427,500
Operating income (loss)			2,157,718			(787,628	)		1,886,953			(2,234,313	)
Net income (loss)		$	2,183,308		$	(1,179,344	)	$	1,982,848		$	(2,641,831	)
Basic net income (loss) per share:		$	0.18		$	(0.10	)	$	0.17		$	(0.23	)
Diluted net income (loss) per share:		$	0.17		$	(0.10	)	$	0.15		$	(0.23	)
Weighted average common shares outstanding:
Basic			11,921,532			11,461,020			11,879,225			11,309,011
Diluted			13,135,495			11,461,020			13,136,321			11,309,011

 

4. Discontinued Operations

 

In December 2006, the Company decided to sell its Catalyst Financial Planning & Investment Management, Inc., or Catalyst, subsidiary and discontinue its wealth management activities. The sale of Catalyst closed in January 2007. As of December 31, 2006, Catalyst is being accounted for as held for sale in accordance with SFAS 144. As a result, the revenue and expenses of Catalyst and MCF Wealth Management, LLC for 2006 have been reclassified and included in discontinued operations in the consolidated statements of operations.

The following revenue and expenses have been reclassified as discontinued operations for the three months and six months ended June 30, 2006:

 

		Period Ended June 30, 2006
		Three Months			Six Months
Revenue		$	217,293		$	428,192
Operating expenses:
Compensation and benefits			176,890			373,062
Professional services			20,740			24,904
Occupancy and equipment			22,801			42,993
Communications and technology			7,058			11,213
Depreciation and amortization			13,923			25,825
Travel and entertainment			21,209			33,063
Other expenses			10,011			27,378
			272,632			538,438
Operating loss			(55,339	)		(110,246	)
Interest income, net			1,077			2,044
Net loss		$	(54,262	)	$	(108,202	)

11

---

 

MCF CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS--CONTINUED

(unaudited)

 

 4. Discontinued Operations - Continued

 

The following assets and liabilities of operations held for sale have been included in the condensed consolidated statements of financial condition as of December 31, 2006:

 

Assets:
Cash and cash equivalents		$	68,503
Accounts receivable			11,155
Furniture and equipment			34,234
Intangible assets, net of accumulated amortization of $172,417			314,963
Prepaid expenses and other assets			24,024
		$	452,879
Liabilities:
Accounts payable			--
Commissions and bonus payable			8,368
Accrued liabilities			87,176
Capital leases			--
		$	95,544

 

5. Income Taxes

At the end of each interim reporting period the Company calculates an effective tax rate based on the Company's estimate of the tax provision (benefit) that will be provided for the full year, stated as a percentage of estimated annual pre-tax income (loss). The tax provision (benefit) for the interim period is determined using this estimated annual effective tax rate. For the six months ended June 30, 2007 and 2006, the Company recorded $55,000 and $0 as income tax expense.

The effective tax rate differs from the statutory rate primarily due to the existence and utilization of net operating loss carryforwards which have been offset by a valuation allowance resulting in a tax provision equal to the companies expected current expense for the year. The Company historically has had current tax expense primarily related to alternative minimum, state and minimum tax liabilities.     

 

Historically and currently, the Company has recorded a valuation allowance on the deferred tax assets, the significant component of which relates to net operating loss tax carryforwards. Management continually evaluates the realizability of its deferred tax assets based upon negative and positive evidence available. Based on the evidence available at this time, the Company continues to conclude that it is not "more likely than not" that we will be able to realize the benefit of our deferred tax assets in the future.

In July 2006, the FASB issued Interpretation No. 48, Accounting for Uncertainty in Income Taxes - an Interpretation of FASB Statement 109 (“FIN 48”). FIN 48 is effective for fiscal years beginning after December 15, 2006. FIN 48 prescribes a comprehensive model for how a company should recognize, measure, present, and disclose in its financial statements uncertain tax positions that a company has taken or expects to take on a tax return (including a decision whether to file or not to file a return in a particular jurisdiction). Under FIN 48, the financial statements reflect expected future tax consequences of such positions presuming the taxing authorities' full knowledge of the position and all relevant facts, but without considering time values. MCF Corporation adopted Interpretation No. 48 on January 1, 2007.

As a result of the implementation of FIN 48, the Company recognized no adjustment in the liability for unrecognized income tax benefits and no corresponding change in retained earnings. The Company does not have any material accrued interest or penalties associated with any unrecognized tax benefits. Other than as discussed below, the Company does not believe it is reasonably possible that the Company's unrecognized tax benefits will significantly change within the next twelve months. The Company's policy is to account for interest, if any, as interest expense and penalties as income tax expense.

There were no unrecognized tax benefits as of June 30, 2007. The Company is subject to taxation in the US and various state and foreign jurisdictions. The tax years 2002-2006 remain open to examination by the federal and most state tax authorities.

12

---

 

MCF CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS--CONTINUED

(unaudited)

 

6. Earnings (loss) per Share

 

The following is a reconciliation of the basic and diluted net income (loss) available to common stockholders and the number of shares used in the basic and diluted net income (loss) per common share computations for the periods presented:

		Three Months Ended June 30,						Six Months Ended June 30,
		2007			2006			2007			2006
Net income (loss) available to stockholders - basic		$	2,320,373		$	(1,059,935	)	$	2,389,629		$	(2,409,543	)
Interest on dilutive securities			4,084			─			8,168			─
Net income (loss) available to stockholders - diluted		$	2,324,457		$	(1,059,935	)	$	2,397,797		$	(2,409,543	)
Weighted-average number of common shares - basic			11,657,775			9,960,900			11,000,702			9,808,891
Exercise or conversion of all potentially dilutive common shares outstanding			1,198,531			─			1,208,263			─
Weighted-average number of common shares - diluted			12,856,306			9,960,900			12,208,965			9,808,891
Basic net income (loss) per common share:
Income (loss) from continuing operations		$	0.20		$	(0.10	)	$	0.22		$	(0.23	)
Loss from discontinued operations		$	─		$	(0.01	)	$	─		$	(0.01	)
Net income (loss)		$	0.20		$	(0.11	)	$	0.22		$	(0.24	)
Diluted net loss per common share:
Income (loss) from continuing operations		$	0.18		$	(0.10	)	$	0.20		$	(0.23	)
Loss from discontinued operations		$	─		$	(0.01	)	$	─		$	(0.01	)
Net income (loss)		$	0.18		$	(0.11	)	$	0.20		$	(0.24	)

Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding, excluding shares of non-vested stock. Diluted earnings per share is calculated by dividing net income, plus interest and dividends on dilutive securities, by the weighted average number of common shares used in the basic earnings per share calculation plus the number of common shares that would be issued assuming exercise or conversion of all potentially dilutive common shares outstanding, including non-vested stock. Diluted loss per share is unchanged from basic loss per share for the three months and six months ended June 30, 2006 because the addition of common shares that would be issued assuming exercise or conversion would be anti-dilutive.

  

Shares used in the diluted net income per share computation include the dilutive impact of the Company's stock options and warrants. The impact of the Company's stock options and warrants on shares used for the diluted earnings per share computation is calculated based on the average share price of the Company's common stock for each period using the treasury stock method. Under the treasury stock method, the tax-effected proceeds that would be hypothetically received from the exercise of all stock options and warrants with exercise prices below the average share price of the Company's common stock are assumed to be used to repurchase shares of the Company's common stock. Because the Company reported a net loss during the three months and six months ended June 30, 2006, the Company excluded the impact of all stock options and warrants in the computation of dilutive earnings per share, as their effect would be anti-dilutive.

13

---

 

MCF CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS--CONTINUED

(unaudited)

 

6. Earnings (loss) per Share - continued

The Company excludes all potentially dilutive securities from its diluted net income (loss) per share computation when their effect would be anti-dilutive. The following common stock equivalents were excluded from the earnings per share computation, as their inclusion would have been anti-dilutive:

		Three Months Ended June 30,						Six Months Ended June 30,
		2007			2006			2007			2006
Stock options and warrants excluded due to the exercise price exceeding the average fair value of the Company's common stock during the period			1,682,257			1,296,243			1,637,949			1,174,825
Weighted average non-vested stock, stock options and stock warrants, calculated using the treasury stock method, that were excluded due to the Company reporting a net loss during the period			─			2,170,446			─			2,192,989
Weighted average shares issuable upon conversion of the convertible notes payable			─			902,736			─			629,851
Weighted average shares contingently issuable			─			52,876			─			94,270
Total common stock equivalents excluded from diluted net income (loss) per share			1,682,257			4,422,301			1,637,949			4,091,935

7. Other Operating Expenses

 

The following expenses are included in other operating expenses for the three months and six months ended June 30, 2007:

		Three Months Ended June 30,						Six Months Ended June 30,
		2007			2006			2007			2006
Investor conferences		$	259,982		$	226,517		$	388,371		$	280,908
Recruiting			227,053			34,658			370,061			129,896
Bad debt expenses			217,922			(467,878	)		228,166			(445,016	)
Public and investor relations			112,780			79,325			160,711			174,001
Supplies			79,355			85,293			167,707			154,563
Insurance			74,547			65,759			147,004			130,869
Other			152,776			129,987			254,339			110,065
		$	1,124,415		$	153,661		$	1,716,359		$	535,286

8. Regulatory Requirements

 

Merriman Curhan Ford & Co. is a broker-dealer subject to Rule 15c3-1 of the Securities and Exchange Commission, which specifies uniform minimum net capital requirements, as defined, for their registrants. As of June 30, 2007, Merriman Curhan Ford & Co. had regulatory net capital, as defined, of $8,875,000, which exceeded the amount required by $7,875,000. Merriman Curhan Ford & Co. is exempt from Rules 15c3-3 and 17a-13 under the Securities Exchange Act of 1934 because it does not carry customer accounts, nor does it hold customer securities or cash.

·

Capital Raising - Capital raising includes private placements of equity and debt instruments and underwritten public offerings.

 

·

Financial Advisory - Financial advisory includes advisory assignments with respect to mergers and acquisitions, divestures, restructurings and spin-offs.

 

The following table sets forth our revenue and transaction volumes from our investment banking activities for the three months and six months ended June 30, 2007 and 2006:

		Three Months Ended						Six Months Ended
		June 30, 2007			June 30, 2006			June 30, 2007			June 30, 2006
Revenue:
Capital raising		$	5,126,556		$	7,330,108		$	9,146,527		$	9,235,003
Financial advisory			505,000			155,000			717,500			675,885
Total investment banking revenue		$	5,631,556		$	7,485,108		$	9,864,027		$	9,910,888
Transaction Volumes:
Public offerings:
Capital underwritten participations		$	72,750,000		$	72,528,000		$	105,250,000		$	104,150,000
Number of transactions			4			8			7			10
Private placements:
Capital raised		$	22,985,000		$	84,000,000		$	86,585,000		$	88,000,000
Number of transactions			3			2			6			4

 

Our investment banking revenue was $5,632,000, or 28% of our revenue during second quarter 2007, representing a 25% decrease from the similar quarter in 2006. Second quarter of 2006 represented our second largest quarter for investment banking revenue and included a $78 million private placement that resulted in a $3.9 million fee. Investment banking revenue for the three months ended June 30, 2007 was in line with average revenue for the preceding four quarters. We led two secondary public offerings during the latest quarter and participated with two underwritten offerings as co-manager. Additionally, we were placement agent for four private placements during the three months ended June 30, 2007.

 

During the six months ended June 30, 2007, no single investment banking client accounted for more than 10% of our revenue, while one investment banking client accounted for 15% of our revenue during the first half of 2006.

17

---

 

Commissions and Principal Transactions Revenue

 

Our broker-dealer activity includes the following:

 

·

Commissions - Commissions include revenue resulting from executing stock trades for exchange-listed securities, over-the-counter securities and other transactions as agent.

 

·

Principal Transactions - Principal transactions consist of a portion of dealer spreads attributed to our securities trading activities as principal in NASDAQ-listed and other securities, and include transactions derived from our activities as a market-maker. Additionally, principal transactions include gains and losses resulting from market price fluctuations that occur while holding positions in our trading security inventory.

 

The following table sets forth our revenue and several operating metrics which we utilize in measuring and evaluating performance and the results of our trading activity operations:

		Three Months Ended						Six Months Ended
		June 30, 2007			June 30, 2006			June 30, 2007			June 30, 2006
Revenue:
Commissions		$	7,717,573		$	7,945,580		$	14,883,280		$	16,643,708
Principal transactions:
Customer principal transactions, proprietary trading and market making		$	4,669,144		$	(815,666	)	$	7,354,753		$	(127,733	)
Investment portfolio			1,043,508			79,715			971,023			(204,917	)
Total principal transactions revenue		$	5,712,652		$	(735,951	)	$	8,325,776		$	(332,650	)
Transaction Volumes:
Number of shares traded			247,476,532			244,983,930			477,147,878			507,732,048
Number of active clients			408			383			488			469

Commissions amounted to $7,718,000, or 38%, of our revenue during the second quarter 2007, representing a 3% decrease from the similar period in 2006. Lower brokerage commissions were partially offset by higher revenue for brokering institutional money funds by our Institutional Cash Distributors division.

 

Principal transactions revenue swung from a $736,000 loss during the second quarter 2006 to a $5,713,000 gain during the second quarter of 2007. The 2007 gain included increases in the mark-to-fair market value of positions in our proprietary trading account, increased profitability in our market making activities, as well as realized and unrealized gains in our investment portfolio. As of June 30, 2007, we made markets in over 1,100 stocks, which has increased by nearly 50% from June 30, 2006. We view “intelligent market making” as a key element to differentiating ourselves from our competition in small capitalization equities. Principal transactions revenue consists of four different activities - customer principal trades, market making, trading for our proprietary account, and realized and unrealized gains and losses in our investment portfolio. As a broker-dealer, we account for all of our marketable security positions on a trading basis and as a result, all security positions are marked to fair market value each day. Returns from market making and proprietary trading activities tend to be more volatile than acting as agent or principal for customers.

 

During 2007 and 2006, no single brokerage customer accounted for more than 10% of our revenue from continuing operations.

Primary Research Revenue

 

 Primary research revenue represents results of MedPanel's operations from the acquisition date, April 17, 2007, through June 30, 2007.  We are now offering independent market data and information to clients in the biotechnology, pharmaceutical, medical device, and financial industries by leveraging MedPanel’s proprietary methodology and vast network of medical experts.

18

---

Compensation and Benefits Expenses

 

Compensation and benefits expense represents the largest component of our operating expenses and includes incentive compensation paid to sales, trading, research and investment banking professionals, as well as discretionary bonuses, salaries and wages, and stock-based compensation. Incentive compensation varies primarily based on revenue production. Discretionary bonuses paid to research analysts also vary with commissions revenue production but includes other qualitative factors as well. Salaries, payroll taxes and employee benefits tend to vary based on overall headcount.

The following table sets forth the major components of our compensation and benefits for the three months ended June 30, 2007 and 2006:

		Three Months Ended						Six Months Ended
		June 30, 2007			June 30, 2006			June 30, 2007			June 30, 2006
Incentive compensation and discretionary bonuses		$	7,708,451		$	7,608,383		$	13,383,686		$	13,253,141
Salaries and wages			3,559,646			2,288,814			6,599,791			4,334,897
Stock-based compensation			714,159			1,047,908			1,451,862			1,982,049
Payroll taxes, benefits and other			784,831			774,214			2,142,035			1,883,005
Total compensation and benefits		$	12,767,087		$	11,719,319		$	23,577,374		$	21,453,092
Total compensation and benefits as a percentage of revenue			63	%		79	%		68	%		81	%
Cash compensation and benefits as a percentage of revenue			59	%		72	%		64	%		74	%

The increase in compensation and benefits expense of $1,048,000 or 9%, from the second quarter 2006 to the second quarter 2007 was due primarily to higher incentive compensation which is directly correlated to revenue production. Cash compensation is equal to total compensation and benefits expense excluding stock-based compensation, which is a non-cash expense. Cash compensation and benefits expense as a percentage of revenue decreased to 59% during the three months ended June 30, 2007 as compared to 72% during the similar period in 2006. This improvement was largely attributed to our proprietary trading gains during 2007 since the gains increased revenue but did not impact compensation and benefits expense.

 

No single sales professional accounted for more than 10% of our revenue during the six months ended June 30, 2007 and 2006.

 

Stock-based compensation expense decreased by $334,000 during the second quarter 2007, as compared to the similar quarter in 2006. The decline in stock-based compensation expense was due in part to fewer non-vested restricted shares outstanding in 2007.

Other Operating Expenses

Brokerage and clearing fees include trade processing expenses that we pay to our clearing broker and execution fees that we pay to floor brokers and electronic communication networks. Merriman Curhan Ford & Co. is a fully-disclosed broker-dealer, which has engaged a third party clearing broker to perform all of the clearance functions. The clearing broker-dealer processes and settles the customer transactions for Merriman Curhan Ford & Co. and maintains the detailed customer records. Additionally, security trades are executed by third-party broker-dealers and electronic trading systems. These expenses are almost entirely variable with commission revenue and the volume of brokerage transactions. Our brokerage and clearing fees decreased by $44,000, or 6%, during the second quarter of 2007 as compared to the second quarter of 2006 and decreased by $94,000, or 7%, during the six months ended June 30, 2007 as compared to the similar period in 2006. This decrease reflected lower commissions revenue during 2007, partially offset by increased market making activity during first half of 2007 as compared to first half of 2006.

Costs of primary research revenue principally consist of panelist honorarium and recruitment costs. Medical experts receive cash honoraria for participating in qualitative panels and quantitative surveys. We pay the honoraria to the panelists when the panel or survey has been completed and record this expense as incurred. We closed the acquisition of MedPanel on April 17, 2007 and began recognizing primary research revenue and related expenses since that date.

19

---

 

Professional services expense includes legal fees, accounting fees, expenses related to investment banking transactions, consulting fees and recruiting fees. Many of these expenses, such as legal and accounting fees, are to a large extent fixed in nature. The decrease of $138,000, or 16%, during the second quarter of 2007 as compared to the second quarter of 2006 and decrease of $198,000, or 15%, during the six months ended June 30, 2007 as compared to the similar period in 2006 was primarily attributed to lower attorney fees associated with business development activities and lower accounting and auditing expenses.

Occupancy and equipment includes rental costs for our office facilities and equipment, as well as equipment, software and leasehold improvement expenses. These expenses are largely fixed in nature. The increase of $46,000, or 11%, during the second quarter of 2007 as compared to the second quarter of 2006 and increase of $106,000, or 14%, during the six months ended June 30, 2007 as compared to the similar period in 2006 resulted mostly from higher hardware and equipment expenses that were incurred in connection with various technology projects.

Communications and technology expense includes market data and quote services, voice, data and Internet service fees, and data processing costs. Historically, these costs have increased as we hire additional employees. The increase of $166,000, or 23%, during the second quarter of 2007 as compared to the second quarter of 2006 and increase of $373,000, or 28% during the six months ended June 30, 2007 as compared to the similar period in 2006 was primarily due to upgrading our trading order management system, as well as the increase in market data and quote services as we continue to expand our market maker activities.

 

Depreciation and amortization expense primarily relate to the depreciation of our computer equipment and leasehold improvements. Depreciation and amortization is mostly fixed in nature. The increase of $23,000, or 14%, during the second quarter of 2007 as compared to the second quarter of 2006 and increase of $52,000, or 17% during the six months ended June 30, 2007 as compared to the similar period in 2006 was due to increased capital expenditures during 2006, including leasehold improvements to our San Francisco office, to facilitate our growth and expansion.

Identifiable intangible assets capitalized in connection with the acquisition of MedPanel included customer relationships, customer backlog, technology platform and the database of registered panelists. The estimated fair market value of these amortizable intangible assets amounting to $1,990,000 will be amortized over periods ranging from 8 months to 56 months.

Travel and entertainment expense results from business development activities across our various businesses. The decrease of $145,000, or 17%, during the second quarter of 2007 as compared to the second quarter of 2006 and decrease of $194,000, or 14% during the six months ended June 30, 2007 as compared to the similar period in 2006 was due mostly to our focus to minimize discretionary spending in an effort to improve profitability.

 

The following expenses are included in other operating expenses for the three months and six months ended June 30, 2007:

		Three Months Ended June 30,						Six Months Ended June 30,
		2007			2006			2007			2006
Investor conferences		$	259,982		$	226,517		$	388,371		$	280,908
Recruiting			227,053			34,658			370,061			129,896
Bad debt expenses			217,922			(467,878	)		228,166			(445,016	)
Public and investor relations			112,780			79,325			160,711			174,001
Supplies			79,355			85,293			167,707			154,563
Insurance			74,547			65,759			147,004			130,869
Other			152,776			129,987			254,339			110,065
		$	1,124,415		$	153,661		$	1,716,359		$	535,286

The increase in other operating expenses of 971,000 during the second quarer of 2007 as compared to the second quarter of 2006 and $1,181,000 increase during the six months ended June 30, 2007 as compared to the similar period in 2006 was due to (i) the recovery in April 2006 of the $500,000 note receivable from Ascend that had been previously written-off in 2005, (ii) higher recruiting costs for some senior investment bankers and institutional sales professionals during the most recent quarter and (iii) the write-off of uncollectible receivables during the three months ended June 30, 2007.

20

---

 

Income Tax Expense

At the end of each interim reporting period we calculate an effective tax rate based on our best estimate of the tax provision (benefit) that will be provided for the full year, stated as a percentage of estimated annual pre-tax income (loss). The tax provision (benefit) for the interim period is determined using this estimated annual effective tax rate. For the six months ended June 30, 2007 and 2006, we recorded $55,000 and $0 as income tax expense.

The effective tax rate differs from the statutory rate primarily due to the existence and utilization of net operating loss carryforwards which have been offset by a valuation allowance resulting in a tax provision equal to the companies expected current expense for the year. We historically have had current tax expense primarily related to alternative minimum, state and minimum tax liabilities.     

Historically and currently, we have recorded a valuation allowance on our deferred tax assets, the significant component of which relates to net operating loss tax carryforwards. Management continually evaluates the realizability of its deferred tax assets based upon negative and positive evidence available. Based on the evidence available at this time, we continue to conclude that it is not "more likely than not" that we will be able to realize the benefit of our deferred tax assets in the near future.

We adopted Interpretation No. 48 on January 1, 2007. As a result of the implementation of FIN 48, we recognized no adjustment in the liability for unrecognized income tax benefits and no corresponding change in retained earnings. We do not have any material accrued interest or penalties associated with any unrecognized tax benefits. Other than as discussed below, we do not believe it is reasonably possible that our unrecognized tax benefits will significantly change within the next twelve months. There were no unrecognized tax benefits as of June 30, 2007. We are subject to taxation in the US and various state and foreign jurisdictions. The tax years 2002-2006 remain open to examination by the federal and most state tax authorities.

Loss from Discontinued Operations

 

In December 2006, we decided to sell our Catalyst subsidiary and discontinue our wealth management activities. The sale of Catalyst closed in January 2007. As of December 31, 2006, Catalyst was accounted for as held for sale in accordance with SFAS 144. As a result, the revenue and expenses of Catalyst and MCF Wealth Management, LLC for 2006 have been reclassified and included in discontinued operations in the condensed consolidated statements of operations.

Off-Balance Sheet Arrangements

We were not a party to any off-balance sheet arrangements during the six months ended June 30, 2007 and 2006. In particular, we do not have any interest in so-called limited purpose entities, which include special purpose entities and structured finance entities.

 

Commitments

The following is a table summarizing our significant commitments as of June 30, 2007, consisting of debt payments related to convertible notes payable, non-convertible notes payable, capital leases and future minimum lease payments under all non-cancelable operating leases with initial or remaining terms in excess of one year.

 

		NotesPayable			Operating Leases			Capital Leases
Less than one year		$	53,388			1,011,684			299,498
One year to three years			243,990			3,179,296			769,607
Three years to five years			--			985,839			--
Total commitments		$	297,378		$	5,176,819		$	1,069,105

 

Critical Accounting Policies and Estimates

 

The consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States, which require us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including those related to the valuation of securities owned and deferred tax assets. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. We believe the following critical accounting policies affect our more significant judgments and estimates used in the preparation of our consolidated financial statements.

21

---

 

Revenue Recognition

 

Investment banking revenue includes underwriting and private placement agency fees earned through our participation in public offerings and private placements of equity and convertible debt securities and fees earned as financial advisor in mergers and acquisitions and similar transactions. Underwriting revenue is earned in securities offerings in which we act as an underwriter and includes management fees, selling concessions and underwriting fees. Fee revenue relating to underwriting commitments is recorded when all significant items relating to the underwriting cycle have been completed and the amount of the underwriting revenue has been determined. This generally is the point at which all of the following have occurred: (i) the issuer's registration statement has become effective with the SEC, or other offering documents are finalized, (ii) the Company has made a firm commitment for the purchase of the shares or debt from the issuer, and (iii) the Company has been informed of the exact number of shares or the principal amount of debt that it has been allotted. Syndicate expenses related to securities offerings in which we act as underwriter or agent are deferred until the related revenue is recognized or we determine that it is more likely than not that the securities offerings will not ultimately be completed. Merger and acquisition fees and other advisory service revenue are generally earned and recognized only upon successful completion of the engagement. Underwriting revenue is presented net of related expenses. Unreimbursed expenses associated with private placement and advisory transactions are recorded as expenses as incurred. As co-manager for registered equity underwriting transactions, management must estimate our share of transaction related expenses incurred by the lead manager in order to recognize revenue. Transaction related expenses are deducted from the underwriting fee and therefore reduces the revenue that is recognized as co-manager. Such amounts are adjusted to reflect actual expenses in the period in which we receive the final settlement, typically 90 days following the closing of the transaction.

Commissions revenue and related clearing expenses are recorded on a trade-date basis as security transactions occur. Principal transactions in regular-way trades are recorded on the trade date, as if they had settled. Profit and loss arising from all securities and commodities transactions entered into for the account and risk of our company are recorded on a trade-date basis.

Primary research revenue is recognized on a proportional performance basis as services are provided.

Valuation of Securities Owned

 

“Securities owned” and “Securities sold, but not yet purchased” in our consolidated statements of financial condition consist of financial instruments carried at fair value or amounts that approximate fair value, with related unrealized gains or losses recognized in our results of operations. The use of fair value to measure these financial instruments, with related unrealized gains and losses recognized immediately in our results of operations, is fundamental to our financial statements and is one of our most critical accounting policies. The fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced or liquidation sale.

Fair values of our financial instruments are generally obtained from quoted market prices in active markets, broker or dealer price quotations, or alternative pricing sources with reasonable levels of price transparency. To the extent certain financial instruments trade infrequently or are non-marketable securities and, therefore, have little or no price transparency, we value these instruments based on management's estimates. The fair value of these securities is subject to a high degree of volatility and may be susceptible to significant fluctuation in the near term. Securities that contain restrictions are stated at a discount to the value of readily marketable securities. Stock warrants are carried at a discount to fair value as determined by using the Black-Scholes Option Pricing model.

 

Stock-Based Compensation

 

On January 1, 2006, we adopted SFAS 123(R), “Share-Based Payment,” which requires the measurement and recognition of compensation expense, based on estimated fair values, for all share-based awards, made to employees and directors, including stock options, non-vested stock, and participation in our employee stock purchase plan. Share-based compensation expense recognized in our consolidated statement of operations for the three months and six months ended June 30, 2007 and 2006 includes compensation expense for share-based awards granted (i) prior to, but not yet vested as of December 31, 2005, based on the grant date fair value estimated in accordance with the provisions of SFAS 123, and (ii) subsequent to December 31, 2005, based on the grant date fair value estimated in accordance with the provisions of SFAS 123(R).